EN
HI

Kabra Drugs Share price

KABRADG

17.68

0.29 (-1.61%)
Last updated on 30 Sep, 2025 | 15:26 IST
BUYSELL
Today's High

18.00

Today's Low

17.08

52 Week Low

9.14

52 Week High

22.77

The current prices are delayed, login to your account for live prices

Kabra Drugs Share Key Metrics

Volume
65789.00
Market Cap
42.60 CR
LTQ@LTP
500@17.68
ATP
17.39
Var Margin
100 %
Circuit Range
17.08-18.86
Delivery %
0 %
Value
11.44 L
ASM/GSM
No
Market Lot
1

Kabra Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

39.1

Sector P/B

3.55

Sec. Div. Yield

0.55

No Data Found

Kabra Drugs Futures & Options

Data Not Found

Kabra Drugs Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2020-21
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
  • 2021-22
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

0%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

100%

Others

0%

Total Promoters
MAR '25
0%
JUN '25
0%

Kabra Drugs Corporate Actions

DateAgenda
2025-09-02Others
2025-08-14Quarterly Results
2025-08-06Others
2025-06-18Others
2025-05-30Audited Results
2025-02-14Quarterly Results
2024-11-14Quarterly Results
2024-11-04Others
2024-08-14Quarterly Results

Kabra Drugs News

No Data Found

About Kabra Drugs

NSE : 0  
BSE : 524322  
ISIN : INE323K01017  

Kabra Drugs Management

NamePosition
Mr. N Aravind Managing Director
Mr. Bangalore Venkatakrishnappa Ananth Kumar WholeTime Director & CFO
View More

Kabra Drugs FAQs

The Buying Price of Kabra Drugs share is 17.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 39.1 & 3.55 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kabra Drugs is 42.60 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kabra Drugs share price is 22.77 & 9.14. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Kabra Drugs belongs to the Healthcare sector.